Abstract
Having elevated blood pressure or hypertension increases ones risk for renal failure, stroke, cardiovascular disease and mortality. Therefore, timely and effective treatment of hypertension can have dramatic implications on patient outcomes and quality of life. Today, health care providers have a number of treatment modalities at their disposal, one of which consists of “lifestyle therapy”. These therapies attempt to reduce blood pressure by altering patient behaviour. Over the last few decades, a number of key studies have highlighted the benefit of lifestyle therapy for the treatment and reduction of hypertension, so much so that all major hypertension associations espouse the use of lifestyle therapy as a first line therapy or in combination with pharmacological therapy. These lifestyle therapies, which include alterations in diet (increasing the amount of fruits and vegetables, reducing the amount of dietary fat and simple carbohydrates), reducing dietary sodium, participating in regular physical activity, reducing weight, and psychosocial interventions, have been shown to dramatically reduce blood pressure. Understanding the benefits and challenges of implementing lifestyle therapies for the treatment of hypertension can lead to better uptake of these practices and improve patient outcomes.
Keywords: hypertension, lifestyle intervention, exercise, weight loss, dietary changes, sodium restriction
Current Hypertension Reviews
Title: Lifestyle Modifications in the Treatment of Hypertension
Volume: 4 Issue: 4
Author(s): Matthew T. Bennett, Andrew Ignaszewski and Scott A. Lear
Affiliation:
Keywords: hypertension, lifestyle intervention, exercise, weight loss, dietary changes, sodium restriction
Abstract: Having elevated blood pressure or hypertension increases ones risk for renal failure, stroke, cardiovascular disease and mortality. Therefore, timely and effective treatment of hypertension can have dramatic implications on patient outcomes and quality of life. Today, health care providers have a number of treatment modalities at their disposal, one of which consists of “lifestyle therapy”. These therapies attempt to reduce blood pressure by altering patient behaviour. Over the last few decades, a number of key studies have highlighted the benefit of lifestyle therapy for the treatment and reduction of hypertension, so much so that all major hypertension associations espouse the use of lifestyle therapy as a first line therapy or in combination with pharmacological therapy. These lifestyle therapies, which include alterations in diet (increasing the amount of fruits and vegetables, reducing the amount of dietary fat and simple carbohydrates), reducing dietary sodium, participating in regular physical activity, reducing weight, and psychosocial interventions, have been shown to dramatically reduce blood pressure. Understanding the benefits and challenges of implementing lifestyle therapies for the treatment of hypertension can lead to better uptake of these practices and improve patient outcomes.
Export Options
About this article
Cite this article as:
Bennett T. Matthew, Ignaszewski Andrew and Lear A. Scott, Lifestyle Modifications in the Treatment of Hypertension, Current Hypertension Reviews 2008; 4 (4) . https://dx.doi.org/10.2174/157340208786241345
DOI https://dx.doi.org/10.2174/157340208786241345 |
Print ISSN 1573-4021 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6506 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
On the Biomaterials for Nanostructured Ocular Therapeutics
Current Organic Chemistry Acknowledgements to Reviewers
Current Hypertension Reviews Pharmacological Management Options to Prevent and Reduce Ischemic Hemorrhagic Transformation
Current Drug Targets Editorial [Hot Topic: G-Protein-Coupled Receptors (GPCRs) and Drug Discovery (Guest Editor: Luca Gentilucci)]
Current Drug Targets Psychological Problems in Female Fragile X Premutations Carriers
Current Psychiatry Reviews Cervicocranial Arterial Dissection: An Analysis of the Clinical Features, Prognosis, and Treatment Efficacy
Current Neurovascular Research Pre-CKD- Do we Need Another Hero?
Current Vascular Pharmacology Heart Failure in Acute Ischemic Stroke
Current Cardiology Reviews Redox Mechanisms of Vascular Cell Dysfunction in Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Diabetic Vascular Complications: Pathophysiology, Biochemical Basis and Potential Therapeutic Strategy
Current Pharmaceutical Design Targeting the Cancer-Stroma Interaction: A Potential Approach for Pancreatic Cancer Treatment
Current Pharmaceutical Design Anti-Hypertensive
Current Bioactive Compounds Dose-related Effects of Resveratrol in Different Models of Pulmonary Arterial Hypertension: A Systematic Review
Current Cardiology Reviews Shedding Light on the Pathophysiology of Preeclampsia-Syndrome in the Era of Cardio-Obstetrics: Role of Inflammation and Endothelial Dysfunction
Current Hypertension Reviews Type 2 Diabetes and Heart Failure: Challenges and Solutions
Current Cardiology Reviews Adrenomedullin Function in Vascular Endothelial Cells: Insights from Genetic Mouse Models
Current Hypertension Reviews Myocardial Expression of TNF-α, IL-1β, IL-6, IL-8, IL-10 and MCP-1 After a Single MDMA Dose Administered in a Rat Model
Current Pharmaceutical Biotechnology Oxidative Stress and Endothelial Dysfunction in Cardiovascular Disease: Mitochondria-Targeted Therapeutics
Current Medicinal Chemistry Herpes Simplex Virus-Induced Ocular Diseases: Detrimental Interaction Between Virus and Host
Current Immunology Reviews (Discontinued) Metabolic Syndrome as a Modifier of Atherosclerosis in Murine Models
Current Drug Targets